High throughput quantification of apolipoproteins A‐I and B‐100 by isotope dilution MS targeting fast trypsin releasable peptides without reduction and alkylation

PURPOSE: Apolipoprotein A‐I (ApoA‐I) and apolipoprotein B‐100 (ApoB‐100) are amphipathic proteins that are strong predictors of cardiovascular disease risk. The traceable calibration of apolipoprotein assays is a persistent challenge, especially for ApoB‐100, which cannot be solubilized in purified...

Descripción completa

Detalles Bibliográficos
Autores principales: Parks, Bryan A, Schieltz, David M, Andrews, Michael L, Gardner, Michael S, Rees, Jon C, Toth, Christopher A, Jones, Jeffrey I, McWilliams, Lisa G, Kuklenyik, Zsuzsanna, Pirkle, James L, Barr, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637893/
https://www.ncbi.nlm.nih.gov/pubmed/28296203
http://dx.doi.org/10.1002/prca.201600128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637893/
https://www.ncbi.nlm.nih.gov/pubmed/28296203
http://dx.doi.org/10.1002/prca.201600128

Ejemplares similares